TrialAnnals of surgery2026

Neoadjuvant Pembrolizumab in Stages I-III Deficient Mismatch Repair Colon Cancer: A Clinical Trial.

Ismail Gögenur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.